MD Anderson Cancer Center

Dr. Filip Janku, MD, PhD is an Assistant Professor in the Department of Investigational Cancer Therapeutics (Phase I Program) at MD Anderson Cancer Center. Dr. Janku obtained his MD and PhD at the Charles University Prague. He joined the program in the 2011 after completion of the fellowship at the same department. Dr. Janku is a principal investigator for numerous phase I, most of which involve novel, targeted agents, many of those being novel first-in-human studies. Dr. Janku received multiple awards for his research efforts, including Sidney Kimmel Scholar award, several ASCO Merit Awards as well as an American Association for Cancer Research Scholar-in-Training Award. Dr. Janku has published over 110 articles in peer-reviewed journals. Dr. Janku's academic research interests focus on poof-of-concept clinical trials that possess a pivotal correlative component especially those involving liquid biopsies, molecular profiling of cell-free DNA, the PI3K/AKT/mTOR pathway and therapeutic use of oncolytic bacteria.